-
B-Lactam Antibiotics (Slide 2)
The "Cillins" all contain B-lactam structure that inhibit transpeptidase (analogues of D-Ala)
Different side chains confer different properties, ranges
Resistence often develops when B-lactamase (penicillinase) gene is acquired by pathogen
Cephalosporins, also have B-lactam structures
-
Vancomycin (Slide 3)
MRSA: Methicilin resistant staphorius. Can use vancomycin
Large MW antibiotic effective against G+ organisms (Not orally bioavailable)
Binds to D-Ala--D-Ala residues and blocks transpeptidase as well as other steps in cell wall synthesis
Resistance due to changing final D-Ala to other AA or similar structure
VRE (Vancomycin Resistant Enterococcus) is known to transfer resistance horizontally.
-
Protein Synthesis Inhibitors (Slide 4)
Aminoglycosides (strepto- and gyntomycin) contain cyclohexane and aminosugars
Binds to 30S ribosomal subunit
Resistance widespread due to enzymatic modification of the antibiotic and mutations in ribosome targets
-
More Protein Synthesis Inhibitors (Slide 5)
Erythromyocin- Macrolide (Large molecule)
Binds to 23S rRNA
Resistance due to change in 23S rRNA sequence or macrolide-digesting enzyme
Chloramphenicol
Chloramphenicol Acetyl Transferase is common gene on Tn's confers
-
Metabolic Antagonists (Slide 6)
Antibiotics that target important biosynthetic pathway in the cell. THF acid pathway required in order to make all bldg blocs for DNA and RNA synthesis
Bacteria use this pathway to make nucleotides from scrath
Sulfonamides (Sulfamethoxazole) are PABA analogues that prevent folic acid production
Resistance is due to mutations in synthetase or by acquiring THF transport genes
-
Metabolic Antagonists Cont. (Slide 7)
Trimethroprim (antibiotic) inhibits DHFR and resistance due to mutations in DHFR/THF transport acquisition
Frequently 2 antibiotics, each inhibiting a diff. step in a common pathway are used together (i.e.: Bactrim or Septra-both containing sulfamethoxazole and trimethroprim)
-
Topoisomerase Inhibitors (Slide 8)
Antibiotics chemically classified as quinolones derived from nalidixic acid. Kill cells and prevent cell division by inhibiting Type II and IV topoisomerases
Resistance due to mutations in topoisomerases, yet not widespread
-
Antibiotic Resistance Mechanisms (Slide 9)
Alter permeability or entry pathway for antibiotic looking to get into the cell
Chemically modify or degrade antibiotic. Are usually found in nature and need little human help
Mutation in target. Can kill off microbes in infected patients and those that survive are those with mutations
Efflux pump confers multidrug resistance
Many resistance-conferring genes are found on transposons and R-plasmids, so horizontal transfer is common
-
Antifungals (Slide 10)
Many antifungals are toxic to host because fungi are eukaryotic and fungal targets often structurally resemble host components
Chitin production in cell wall is obvious potential target, currently being studied
Ergosteroal synthesis/function is common target of many anti-fungals (Azoles, amphotericin, nystatin)
Microtubule is also a target (Griseofulvin)
-
Antiviral Drugs (Slide 11)
Most antiviral drugs target replication, many are nucleoside analogues
Some antivirals have specific targets (HIV protease inhibitor ritonavir, neurominidate inhibitor tamiful, influenza virus uncoating inhibitor amantidine)
Resistance to these drugs is common, because viral replication is often error-prone
-
Making Monoclonal Antibodies (Slide 13)
- Mouse:
- -Inject mouse with antigen
- -Harvest spleen containing B-Cells
- Cells:
- -Fuse spleen cells to myeloma cells (cancerous cell derived intially from B-cell)
- -Isolate each fused cell, grow and screen
- Protein:
- - Grow up high production hybridomas
- -Isolate antibodies (IgMs and IgGs)
-
Immunofluorescence Microscopy (Slide 14)
Uses antibodies and monoclonal-Antibodies covalently attached to fluorescent tags
Direct: Labeled antibody binds directly to antigen on specimen
Indirect: unlabeled antibody binds to specimen and then a labeled AB binds to first AB, not directly to specimen (Can be used to look for Abs in serum --> exposure to antigens)
-
ELISA (Enzyme-linked immunosorbent assay) (Slide 15)
Direct ELISA (sandwich) uses microtiter plates pre-coated w/bound, unlabelled ABs to trap Ag. A 2nd Tagged (enzyme-linked) AB to the Ag is added and the amount of 2nd AB is determined
Often the 2 ABs are different monoclonals, w/diff. binding specificities.
-
ELISA (Enzyme-linked immunosorbent away) (Slide16)
Indirect: Used to look for serum ABs to a particular substance (Exposure): Microtiter plates are pre-coated w/Ag, serum containing primary ABs is added, then tagged (secondary) AB binds to 1st AB, if it is present
Amount of secondary AB is quantified
-
Agglutination Tests (Slide 17)
Used as field test (Crime scene) to check blood sample.
Quick procedure depending on abilities of ABs to from large immune complexes w/ Ags. Complexes so large that they're able to precipitate from solution
Needs several dilutions of ABs and/or antigens, since complexes only form at specific ration of Ab:Ag
Typically IgMs are used, since secreted IgM is pentavalent: 5IgMs are linked together.
|
|